Business Context and Reporting Period
Company: John Wiley & Sons, Inc. (WLY/WLYB)
Filing Type: Form 10-Q (Unaudited)
Period Ended: October 31, 2024 (Fiscal Year 2025 Q2)
Business Overview: Wiley is a global leader in research and learning, operating primarily through two reportable segments: Research (scientific, technical, and medical publishing) and Learning (academic and professional publishing). The company is predominantly digital, with over 83% of revenue generated from digital products and services. The reporting period reflects the completion of a strategic divestiture plan involving non-core businesses: University Services (sold Jan 2024), Wiley Edge (sold May/Aug 2024), and CrossKnowledge (sold Aug 2024).
Key Financial Metrics
| Metric (in thousands, except per share) | Three Months Ended Oct 31, 2024 | Six Months Ended Oct 31, 2024 |
|---|---|---|
| Revenue, Net | $426,595 | $830,404 |
| Operating Income | $64,133 | $93,106 |
| Net Income (Loss) | $40,458 | $39,022 |
| Diluted EPS | $0.74 | $0.71 |
| Adjusted Operating Income (Non-GAAP) | $68,819 | $104,181 |
| Adjusted EBITDA (Non-GAAP) | $105,537 | $178,152 |
| Cash and Cash Equivalents | $75,536 | $75,536 |
| Total Debt Outstanding | $961,010 | $961,010 |
| Net Cash Used in Operating Activities | Not provided for 3 months | $(93,992) |
Note: Operating cash flow is seasonally negative in the first half of the fiscal year due to the timing of journal subscription collections.
Material Changes vs. Prior Comparable Period
- Revenue: Consolidated revenue decreased 13% ($66.2M) for the quarter and 12% ($113.4M) for the six months compared to the prior year. This decline is primarily attributable to the divestiture of University Services, Wiley Edge, and CrossKnowledge. Excluding these divested businesses, Adjusted Revenue increased 3% (quarter) and 5% (six months) on a constant currency basis.
- Profitability: Operating income increased 39% for the quarter and $63.2M for the six months. This improvement is driven by lower restructuring charges ($3.6M vs. $25.1M in the prior quarter) and the absence of a $26.7M goodwill impairment recorded in the prior year. Adjusted Operating Income increased 32% (quarter) and 46% (six months) on a constant currency basis.
- Segment Performance:
- Research: Revenue increased 2% (quarter) and 2% (six months). Growth was driven by Open Access and institutional models, offset by declines in legacy print.
- Learning: Revenue increased 8% (quarter) and 11% (six months). Growth was supported by a $21M GenAI content rights project ($4M recognized in Q2) and improved retail channel performance.
- Divestitures: The company recorded a net gain of $0.4M on the sale of businesses/assets in the quarter and $6.2M for the six months, contrasting with significant losses in the prior year due to impairment charges on held-for-sale assets.
Guidance, Outlook, and Risks
- Restructuring Program: The Global Restructuring Program aims to yield approximately $80 million in annualized cost savings, with $75 million expected to be realized in the current fiscal year. The company reduced real estate occupancy by approximately 35%. Additional restructuring charges are anticipated in future periods related to severance and facility costs.
- Outlook: Management expects continued growth in scientific research output and the transition to open research. Strategies focus on scaling high-value digital content and assessments while managing print revenue declines.
- Risks and Contingencies:
- Divestiture Integration: Risks related to the successful integration of remaining operations and realization of expected savings from divestitures.
- Technology: Reliance on the ability to leverage AI technologies (generative AI, LLMs) in products and services.
- Market Conditions: Exposure to global economic conditions, consolidation of book wholesalers, and the financial stability of journal subscription agents.
- Tax: The effective tax rate for the six months ended Oct 31, 2024, was 45.8%, significantly higher than the prior year, driven by US ordinary losses for which no tax benefit could be recognized due to valuation allowances.
Investor Verification Checklist
- Divestiture Impact: Verify the extent to which reported revenue declines are due to completed divestitures versus organic performance in core Research and Learning segments.
- GenAI Revenue: Assess the sustainability of the $21M GenAI content rights project revenue recognized in the Learning segment and its impact on future growth projections.
- Restructuring Savings: Monitor the realization of the projected $80 million in annualized cost savings from the Global Restructuring Program against ongoing facility and severance charges.
- Cash Flow Seasonality: Confirm the timing of cash collections for journal subscriptions in the second half of the fiscal year to validate liquidity projections.
- Debt Covenants: Review compliance with consolidated net leverage and interest coverage ratios under the Amended and Restated Credit Agreement, particularly given the increase in total debt to $961M.